Eugenia Yazlovitskaya
Faculty Member
Last active: 11/16/2017

  1. Integrin alpha6 maintains the structural integrity of the kidney collecting system. Viquez OM, Yazlovitskaya EM, Tu T, Mernaugh G, Secades P, McKee KK, Georges-Labouesse E, De Arcangelis A, Quaranta V, Yurchenco P, Gewin LC, Sonnenberg A, Pozzi A, Zent R (2017) Matrix Biol : 244-257
    › Primary publication · 28043890 (PubMed) · PMC5330664 (PubMed Central)
  2. Human sterol 14α-demethylase as a target for anticancer chemotherapy: towards structure-aided drug design. Hargrove TY, Friggeri L, Wawrzak Z, Sivakumaran S, Yazlovitskaya EM, Hiebert SW, Guengerich FP, Waterman MR, Lepesheva GI (2016) J Lipid Res 57(8): 1552-63
    › Primary publication · 27313059 (PubMed) · PMC4959870 (PubMed Central)
  3. Integrin α3β1 regulates kidney collecting duct development via TRAF6-dependent K63-linked polyubiquitination of Akt. Yazlovitskaya EM, Tseng HY, Viquez O, Tu T, Mernaugh G, McKee KK, Riggins K, Quaranta V, Pathak A, Carter BD, Yurchenco P, Sonnenberg A, Böttcher RT, Pozzi A, Zent R (2015) Mol Biol Cell 26(10): 1857-74
    › Primary publication · 25808491 (PubMed) · PMC4436831 (PubMed Central)
  4. Cellular oxidative stress response mediates radiosensitivity in Fus1-deficient mice. Yazlovitskaya EM, Voziyan PA, Manavalan T, Yarbrough WG, Ivanova AV (2015) Cell Death Dis : e1652
    › Primary publication · 25695605 (PubMed) · PMC4669799 (PubMed Central)
  5. A novel radioprotective function for the mitochondrial tumor suppressor protein Fus1. Yazlovitskaya EM, Uzhachenko R, Voziyan PA, Yarbrough WG, Ivanova AV (2013) Cell Death Dis : e687
    › Primary publication · 23788044 (PubMed) · PMC3702292 (PubMed Central)
  6. Novel therapeutic approaches for targeting tumor angiogenesis. Linkous AG, Yazlovitskaya EM (2012) Anticancer Res 32(1): 1-12
    › Primary publication · 22213282 (PubMed)
  7. Novel radiosensitizing anticancer therapeutics. Linkous AG, Yazlovitskaya EM (2012) Anticancer Res 32(7): 2487-99
    › Primary publication · 22753705 (PubMed)
  8. Glycogen synthase kinase 3β inhibitors protect hippocampal neurons from radiation-induced apoptosis by regulating MDM2-p53 pathway. Thotala DK, Hallahan DE, Yazlovitskaya EM (2012) Cell Death Differ 19(3): 387-96
    › Primary publication · 21738215 (PubMed) · PMC3193912 (PubMed Central)
  9. CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffolds. Hargrove TY, Kim K, de Nazaré Correia Soeiro M, da Silva CF, Batista DD, Batista MM, Yazlovitskaya EM, Waterman MR, Sulikowski GA, Lepesheva GI (2012) Int J Parasitol Drugs Drug Resist : 178-186
    › Primary publication · 23504044 (PubMed) · PMC3596085 (PubMed Central)
  10. Cytosolic phospholipase A2 as a molecular target for the radiosensitization of ovarian cancer. Schulte RR, Linkous AG, Hallahan DE, Yazlovitskaya EM (2011) Cancer Lett 304(2): 137-43
    › Primary publication · 21397389 (PubMed) · PMC3075208 (PubMed Central)